Kristen Coppock Crossley, MA

David Brathwaite is dvm360's 2026 Veterinary Hero Veterinary Paraprofessional award recipient.

James Mackey, BS, AAS, CVT, CVPP, VTS (Anesthesia & Analgesia), is dvm360's 2026 Veterinary Hero Credentialed Veterinary Technician Award recipient.

Michael Strickland, DVM, DABVP (Canine & Feline Practice), is dvm360's 2026 Veterinary Heroes Lifetime Achievement Award recipient.

The 2026 recognition program honorees will be presented with their awards at the Fetch dvm360 conference in Kansas City, Missouri, later this month.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains intravenous regional limb perfusion in a dvm360 interview.

dvm360's annual conference in Missouri introduces the 2026 Veterinary Heroes and features unique opportunities to network and learn

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, explains how transdermal drug delivery is administered and processed by various animal species, in a dvm360 interview.

Veterinarians answer the call to serve animals in vulnerable regions.

Jessie Ziegler, DVM, MS, DACVIM (LAIM), discusses a key point of her recent lecture at the 2026 ACVIM Forum.

Experts recommend that veterinary teams reassess tick prevention as shifting ranges and emerging pathogens change exposure risks for animals and people.

Joe Smith, DVM, MPS, PhD, DACVIM, DACVCP, cVMA, explains what makes alternative drug delivery unique vs standard drug delivery.

Results of a study on a GLP-1 therapy in development were presented during the 2026 ACVIM Forum.

Elanco's TruCan Ultra Lyme-L4 is a combination therapy that aims to protect dogs against increasing health risks.

The investigation showed improved stool consistency and microbiome balance in cats and dogs.

Educator Megan Chadwick, CVT, discusses how practices can retain veterinary technicians and help grow their careers.

Pimobendan Chewable Tablets were approved by the FDA in 2024 for management of mild, moderate, or severe CHF caused by myxomatous mitral valve disease or dilated cardiomyopathy, as a concurrent therapy.

The event held during the 2026 AVMA Convention will showcase AI, sustainability, antimicrobial stewardship, One Health, and new care models.

Upcoming industry events for earning continuing education credits

BluePearl Pet Hospital will host joint events across the United States.

dvm360 talks with veterinary behavior experts Christopher Pachel, DVM, DACVB, CABC, and Carlo Siracusa, DVM, PhD, DACVB, DECAWBM, about pharmaceuticals that include tasipimidine oral solution (Tessie; Orion Animal Health).

Needle arthroscopy provides direct visualization of the canine hip joint, supporting diagnosis and treatment planning in dogs with hip pain.

Jennifer Miller, DVM, talks about pharmacology innovation and new therapies for canine parvovirus and itch relief.

USDA funds Texas Tech to decode Streptococcus suis risk in pigs, linking microbiome and farm practices to prevent outbreaks and cut antibiotics.

May 20 annually raises awareness about the role of pollinators in maintaining a healthy planet.

Zoetis' doramectin injection is now indicated for use in dairy cows, horses, sheep, swine, and deer to help mitigate NWS myiasis.

Tirnovetmab (Befrena; Elanco) injection received USDA approval in late 2025.

The European Medicines Agency has recommended Nobivac NXT HCPChFelV for market authorization in the European Union.

New research and treatment methods are finding ways to combat the parasitic Varroa mite to save colonies from collapsing.

Jennifer Miller, DVM, discusses how a pet's bond with their owner can benefit outcomes with treatment for skin conditions.

Christopher Pachel, DVM, DACVB, CABC, discusses the value of a drug treatment for dogs that addresses 2 behaviors, rather than separate therapies.